📰 Wavemaker Three Sixty News
Wavemaker Three Sixty News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Wavemaker Three Sixty. Real-time updates on events, politics, business and more.
June 20, 2023
/PRNewswire/ -- Gradient Health, a leading medical AI data-sharing company, announced today the successful closure of a $2.75 million funding round led by ReMY...
June 20, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
January 27, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
January 26, 2023
Also: Digital health firm adds to portfolio, study finds more heart failure in rural areas
August 1, 2022
At the INVEST PhamaTech conference last month, five startups shared their vision for how they are seeking to reinvent clinical trials as part of the Pitch Perfect contest.
July 21, 2022
The conference highlights the convergence of digital health and drug development. Among the panel discussions are a focus on the state of AI in drug discovery and the future of digital medicines. A startup pitch contest spotlights companies seeking to improve clinical trials. Register for free today!
June 23, 2022
The Pitch Perfect contest at MedCity INVEST PharmaTech, the free virtual conference scheduled for July 26, will spotlight five startups seeking to improve clinical trials.
June 14, 2022
At the MedCity INVEST PharmaTech virtual conference July 26, strategies and alignment between digital and pharma companies will be a major theme of the conference. Register now to join the conversation.
June 9, 2022
The MedCity INVEST PhrmaTech virtual conference, scheduled for Tuesday, July 26, offers free registration and a compelling day of conversations exploring the convergence of the health tech and biopharma sectors.
May 6, 2022
INVEST PharmaTech Pitch Perfect virtual conference July 26 will give startups the opportunity to present their approaches to clinical trial innovation to a team of investor judges. Apply today!